Lyme disease vaccine found to be safe and effective in clinical trial
French company Valneva has developed a vaccine that works by stopping Lyme-causing bacteria in ticks from passing into people’s bloodstreams when the ticks bite.
From disease eradication efforts to advances in vaccination and maternal health, this archive tracks real progress in public health. Stories here focus on what’s working — policies, interventions, and research that are improving and extending lives around the world.
French company Valneva has developed a vaccine that works by stopping Lyme-causing bacteria in ticks from passing into people’s bloodstreams when the ticks bite.
A new blood test for prostate cancer is producing a 99% accuracy rating—precision that has never before been achieved for a blood test of this particular kind of cancer. The test can also determine the exact stage and progression of the cancer, reducing the need for invasive biopsies and scans.
One of the largest studies of its kind looked at data from more than seven million patients and found that a seasonal flu shot cut the risk of heart attacks by up to 85 percent, and halved the number of strokes.
At least 200,000 Oklahoman adults will be newly eligible for Medicaid, but program enrollment may climb even higher as the state’s unemployment rate has surged to nearly 13 percent.
The calls were contained in a 225-page manual for church leaders and workers to mark the fifth anniversary of Pope Francis’ landmark encyclical “Laudato Si” on the need to protect nature, life and defenseless people.
Cleveland Clinic researchers have developed the world’s first risk prediction model for healthcare providers to forecast an individual patient’s likelihood of testing positive for COVID-19 as well as their outcomes from the disease.
The new effort provides critical relief in a country where medical workers have discussed work boycotts to protest the lack of protective equipment, especially after several healthcare workers were confirmed infected with the virus.
The aid also includes 900,000 visors, 600,000 hygiene caps, 60,000 medical coats, 30,000 litres of hydroalcoholic gel, 15,000 packs of Azithromycin, and more.
Researchers from Oxford University say said the drug Dexamethasone reduced deaths by 35 percent for patients on ventilators and by 20 percent in those only needing supplemental oxygen.
Researchers at Tulane University School of Medicine have also discovered a way to inhibit an aggressive form of breast cancer from occurring. The animal study results have been so compelling that the team is now working on FDA approval to begin clinical trials.